16th June 2015

Roche employees unite to raise funds for children in need

On 16th June over 200 employees from local company, Roche Diagnostics, took part in a 5K Children’s Walk around Burgess Hill to raise money for charity. The initiative, which coincided with the International Day of the African Child, hoped to raise over £5,000. The money will be shared between the Chestnut Tree House, a Brighton-based charity that provides specialist care to children and young adults with life-threatening illnesses, and charities in Malawi that support children orphaned by HIV/AIDS.

One lucky employee will also be chosen to visit Malawi and see first-hand the difference the money raised can make.  

Christopher Parker, Managing Director of Roche Diagnostics UK and Ireland, said: “It’s great to see so many employees taking part in this year’s Children’s Walk. It is an important initiative which raises money for local charities, as well as supporting children in need overseas.” 

Roche Diagnostics is the world’s largest biotech company. Its UK headquarters is based in Burgess Hill and employs approximately 600 people.

 

-Ends-

Notes to Editor:

For media enquiries please call +44 (0)20 7054 9974 or email roche@weareicg.com

 

About Roche

Since 2003, Roche employee walkers have joined together for the annual Children’s Walk to raise essential funds for vulnerable children worldwide. Almost 80,000 employee walkers at over 100 Roche sites have participated to date, with over 7 million Swiss francs raised.

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit roche.com.

All trademarks used or mentioned in this release are protected by law.